Next Test After Positive HBsAg
Order anti-HBc (total or IgG) and IgM anti-HBc to distinguish between acute and chronic hepatitis B infection. 1
Initial Diagnostic Approach
When HBsAg is positive, the immediate priority is determining whether this represents acute or chronic infection, as this fundamentally changes management:
Essential Next Tests
- IgM anti-HBc: Presence indicates acute or recently acquired infection
- Total anti-HBc (or IgG anti-HBc): Combined with IgM status, this helps establish chronicity
- Anti-HBs: While less critical initially, helps complete the serologic picture 1, 2
The key distinction: IgM anti-HBc appears 1-2 weeks after HBsAg in acute infection and typically becomes undetectable within 6 months, while total anti-HBc (predominantly IgG) persists long-term. If HBsAg persists >6 months, the infection is deemed chronic. 1
Interpretation Framework
Based on the serologic pattern 1, 2:
- HBsAg(+), IgM anti-HBc(+), Total anti-HBc(+) = Acute infection
- HBsAg(+), IgM anti-HBc(-), Total anti-HBc(+) = Chronic infection
- HBsAg(+), All anti-HBc(-) = Early acute infection (within first 1-2 weeks)
Additional Baseline Evaluation
Once acute vs. chronic is established, complete the initial workup 3, 4:
For Confirmed Chronic HBV (HBsAg positive >6 months or negative IgM anti-HBc):
Viral markers:
- HBV DNA quantification (essential for treatment decisions)
- HBeAg and anti-HBe status
- Quantitative HBsAg levels (prognostic value) 4
Liver disease assessment:
- ALT/AST, complete hepatic panel
- Complete blood count with platelets
- Prothrombin time
- Alpha-fetoprotein (AFP) baseline 3
Coinfection screening:
- Anti-HCV (hepatitis C)
- Anti-HDV if from endemic areas or injection drug use history
- Anti-HIV if risk factors present 3
Liver fibrosis assessment:
- Non-invasive testing (VCTE/FibroScan preferred over APRI/FIB-4 in HBV) 4
- Liver biopsy only if results will directly influence treatment decisions 4
Monitoring Schedule After Initial Diagnosis
First year post-diagnosis 4:
- ALT and HBV DNA every 3-6 months to define infection phase
- HBsAg levels every 12 months
- HBeAg/anti-HBe every 12 months (if initially HBeAg-positive)
After first year (if not on treatment):
- ALT and HBV DNA every 6-12 months
- More frequent monitoring if ALT elevates or HBV DNA changes significantly
Critical Pitfalls to Avoid
Don't assume low HBsAg values are false positives without confirmation: While false positives can occur (especially with COI <6.0), confirmatory neutralization testing should be performed for borderline results 5, 6
Don't delay testing contacts: All household contacts and sexual partners need HBsAg testing and vaccination if susceptible 1
Don't miss the reactivation risk: Document HBV status before any immunosuppressive therapy, particularly anti-CD20 antibodies (rituximab), as reactivation can be fatal 7, 8
Don't forget HCC surveillance: Asian men >40, Asian women >50, anyone with cirrhosis, or those with family history of HCC need ultrasound screening every 6-12 months 3